Effects of long-term fenofibrate therapy on cardiovascular events in people with type 2 diabetes mellitus Charles A. Reasner Invited Commentary Pages: 261 - 262
Blood biologic markers of stroke: Improved management, reduced cost? Alison E. Baird OriginalPaper Pages: 267 - 275
Transient ischemic attack: Definition and natural history Louis R. Caplan OriginalPaper Pages: 276 - 280
Imaging the penumbra in acute stroke Ramez R. MoustafaJean-Claude Baron OriginalPaper Pages: 281 - 289
Symptomatic and asymptomatic carotid stenosis: How, when, and who to treat? Peter M. Rothwell OriginalPaper Pages: 290 - 297
Management of symptomatic intracranial arterial stenosis: Endovascular therapy Mikael MazighiAlex Abou-Chebl OriginalPaper Pages: 298 - 303
Hemostatic therapy for intracerebral hemorrhage Fred RinconManuel M. BuitragoStephan A. Mayer OriginalPaper Pages: 304 - 309
Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: Insights from the framingham study William B. KannelPhilip A. Wolf OriginalPaper Pages: 317 - 323
Intracranial atherosclerotic stroke: Specific focus on the metabolic syndrome and inflammation Oh Young Bang OriginalPaper Pages: 330 - 336
Statin therapy for coronary heart disease and its effect on stroke Jeffrey A. SwitzerDavid C. Hess OriginalPaper Pages: 337 - 342
Aortic arch atheroma and the risk of stroke Pierre AmarencoJoachim RötherGeoffrey A. Donnan OriginalPaper Pages: 343 - 346
